Protić-Rosić, I.; Sehgal, A.N.A.; Wrighton, S.; Heller, B.; Pickl, W.F.
Chimeric Autoantibody Receptor- and/or Peptide-MHC-Based CAR Therapies for Targeted Elimination of Antigen-Specific B or T Cells in Hypersensitivity Disorders Such as Allergies and Autoimmune Diseases. Cells 2025, 14, 753.
https://doi.org/10.3390/cells14100753
AMA Style
Protić-Rosić I, Sehgal ANA, Wrighton S, Heller B, Pickl WF.
Chimeric Autoantibody Receptor- and/or Peptide-MHC-Based CAR Therapies for Targeted Elimination of Antigen-Specific B or T Cells in Hypersensitivity Disorders Such as Allergies and Autoimmune Diseases. Cells. 2025; 14(10):753.
https://doi.org/10.3390/cells14100753
Chicago/Turabian Style
Protić-Rosić, Isidora, Al Nasar Ahmed Sehgal, Sebastian Wrighton, Birgit Heller, and Winfried F. Pickl.
2025. "Chimeric Autoantibody Receptor- and/or Peptide-MHC-Based CAR Therapies for Targeted Elimination of Antigen-Specific B or T Cells in Hypersensitivity Disorders Such as Allergies and Autoimmune Diseases" Cells 14, no. 10: 753.
https://doi.org/10.3390/cells14100753
APA Style
Protić-Rosić, I., Sehgal, A. N. A., Wrighton, S., Heller, B., & Pickl, W. F.
(2025). Chimeric Autoantibody Receptor- and/or Peptide-MHC-Based CAR Therapies for Targeted Elimination of Antigen-Specific B or T Cells in Hypersensitivity Disorders Such as Allergies and Autoimmune Diseases. Cells, 14(10), 753.
https://doi.org/10.3390/cells14100753
